Gustavo J. Rodrigo, MD; Mario Rodriquez Verde, MD; Virginia Peregalli, MD; and Carlos Rodrigo, MD
|
|
- Francis Norman
- 6 years ago
- Views:
Transcription
1 Effects of Short-term 28% and 100% Oxygen on PaCO 2 and Peak Expiratory Flow Rate in Acute Asthma* A Randomized Trial Gustavo J. Rodrigo, MD; Mario Rodriquez Verde, MD; Virginia Peregalli, MD; and Carlos Rodrigo, MD Study objective: We conducted the first randomized controlled study to assess the effects of short-term 28% and 100% oxygen on PaCO 2 and peak expiratory flow rate (PEFR) in patients with acute severe asthma. Patients and interventions: Seventy-four patients (mean age, years [ SD]; PEFR, % of predicted) from two emergency departments were randomized to receive 28% or 100% oxygen during 20 min. Results: The administration of 100% oxygen significantly increases PaCO 2 (p 0.03) and decreases PEFR (p 0.001) as compared with administration of 28% oxygen. PaCO 2 before and during oxygen administration correlated significantly (p 0.001) in both groups. Patients breathing 28% oxygen experienced a PaCO 2 fall; on the contrary, patients who received 100% oxygen showed an increase in PaCO 2, particularly those with PaCO 2 before oxygen treatment > 40 mm Hg. Conclusions: This study confirmed previous observations that oxygen dose should be variable and based on achieving and maintaining target arterial oxygen saturation measured by pulse oximetry > 92% rather than on prescribing predetermined concentrations or flow rates of inspired oxygen. (CHEST 2003; 124: ) Key words: acute severe asthma; emergency department treatment; gas exchange; hyperoxia; oxygen; oxygen therapy; uncontrolled oxygen administration Abbreviations: CI confidence interval; PEFR peak expiratory flow rate; Spo 2 pulse oximetric saturation; V /Q ventilation/perfusion Asthma exacerbations are potentially life threatening. Studies of near-fatal asthma suggest that hypoxemia is probably an important cause of death 1,2 ; therefore, oxygen supplementation is a critical part of the management of patients with acute asthma. 3 5 Because hypoxemia is produced by ventilation/perfusion (V /Q ) mismatch, mostly, it can be corrected by the administration of moderate doses of *From the Departamento de Emergencia (Drs. G. Rodrigo and Peregalli), Hospital Central de las Fuerzas Armadas, Montevideo; Centro de Tratamiento Intensivo (Dr. Rodriguez Verde), Hospital de Paysandú, Paysandú; and Unidad de Cuidado Intensivo (Dr. C. Rodrigo), Asociación Española 1 a de Socorros Mutuos, Montevideo, Uruguay. Manuscript received November 12, 2002; revision accepted March 3, Reproduction of this article is prohibited without written permission from the American College of Chest Physicians ( permissions@chestnet.org). Correspondence to: Gustavo J. Rodrigo, MD, Departamento de Emergencia, Hospital Central de las Fuerzas Armadas. Av. 8 de Octubre 3020, Montevideo 11600, Uruguay; gurodrig@ adinet.com.uy inspired oxygen. 6,7 In spite of this, the use of highflow oxygen by a mask with reservoir bag has been assumed to be harmless and the best way to deliver it to patients with acute asthma Uncontrolled oxygen has been postulated to correct the effects of hypoxemia and to compensate any trend for Pao 2 to fall with -agonist therapy. Nevertheless, there is rising evidence that hyperoxia may be unsafe for some patients. One noncontrolled study 12 suggests that Paco 2 may worsen in some patients receiving 100% oxygen, especially those with more severe airflow obstruction; however, to our knowledge, there are no controlled trials that evaluate the use of oxygen in acute asthma. 13,14 In fact, the Global Strategy for Asthma Management and Prevention report 15 on asthma states that these data need to be validated in a controlled trial, but for now suggest that oxygen therapy should be titrated according to oximetry. Consequently, we conducted a randomized controlled study to assess the effect of admin Clinical Investigations
2 istration of two oxygen concentrations on gas exchange in adult patients with acute severe asthma. Subjects Materials and Methods We recruited all adult patients with acute asthma who were seen in two emergency departments of Uruguay (Hospital Central de las Fuerzas Armadas in Montevideo, and Hospital de Paysandú, in Paysandú) over a 6-month period (March to August 2002). The inclusion/exclusion criteria for patients were as follows: (1) diagnosis criteria of asthma of the American Thoracic Society 16 ; (2) age from 18 to 50 years; (3) peak expiratory flow rate (PEFR) 60% of predicted value; and (4) patients were excluded if they had a temperature 38 C, or a history of cardiac, hepatic, renal disease, or other medical disease, or pregnancy; and (5) an expressed willingness to participate in the study, with written informed consent obtained. The Hospitals Ethics Committees approved the study. Design After baseline measures (the investigators made all measures unaware of the patient group assignments), subjects were randomized (using a computer-generated method) to receive one of two treatments arms. Those in the first treatment arm (28% group) received 28% oxygen for 20 min via a standard facemask (model 1088; Hudson RCI; Temecula, CA). Those in the second treatment arm (100% group) received 100% oxygen for 20 min via a standard nonrebreathing facemask (model 1060; Hudson RCI). Because facemasks used are obvious different (eg, a reservoir bag is only present in the nonrebreathing facemask), the study was not blinded. At the end of oxygen protocol, all patients received albuterol and ipratropium bromide (120 g of albuterol sulfate and 21 g of ipratropium bromide per actuation) delivered by a metered-dose inhaler into a spacer device (Volumatic; Allen & Hanburys; Greenford, UK) in a dose of four puffs at 10-min intervals in accordance with previous evidence. 17,18 Additionally, patients with a poor response received hydrocortisone, 400 mg IV. Measures The following variables were measured in each patient immediately before starting oxygen administration and during the oxygen treatment (at 20 min): PEFR, respiratory rate, heart rate, and arterial blood gases. At baseline, we also assessed the presence of accessory muscle use, dyspnea, and wheezing. PEFR was measured with a mini-wright peak flowmeter (Clement Clarke; Harlow, UK). The highest of three values was recorded. Heart rate was measured from continuous ECG. Accessory muscle use was defined as visible retraction of the sternocleidomastoid muscles. 19 Dyspnea was defined as the patient s own assessment of breathlessness. Wheezing was defined as musical or whistling breath sounds heard with a stethoscope during expiration. These clinical factors were graded in a scale from 0 to 3, in which 0 denoted absent, 1 indicated mild, 2 indicated moderate, and 3 indicated severe. Arterial blood samples were obtained via puncture of the radial artery; and ph, Pao 2, and Paco 2 were measured with a blood gas analyzer using routine techniques (ABL 500 system; Radiometer America; Westlake, OH). Arterial saturation (pulse oximetric saturation [Spo 2 ]) was monitored during oxygen administration by pulse oximetry with a finger oximeter (Nellcor N-180; Nellcor; Hayward, CA). Primary outcome measure was Paco 2 (difference between the two groups and variation from baseline) at the end of oxygen administration. Secondary outcomes variables were ph, PEFR, Pao 2, heart rate, and respiratory rate (differences between groups and variation from baseline) at the end point. Patients unable to maintain a Spo 2 90% and/or presented clinical deterioration during the oxygen protocol were excluded and received inhaled bronchodilators and systemic corticosteroids. Statistical Analysis The study was designed a priori with a sample size of 36 subjects per group to have 80% power to detect ( 0.05, two-tailed test) a mean difference between groups in Paco 2 of 2.4 mm Hg, with a SD of 5 mm Hg. Mean values SD were calculated for continuous variables. The 95% confidence intervals (CIs) were calculated with standard formulas. 20 The two groups were compared with respect to continuous variables using a repeated-measures two-way analysis of variance; post hoc pairwise multiple comparisons were performed using the Scheffé method. Pearson 2 with Yates correction or the Fisher exact test was used for categorical variables. All data were analyzed with SPSS 10.0 for Windows software (SPSS; Chicago, IL). Results A total of 79 consecutive adults with an acute exacerbation of asthma were recruited for entry into this study. Two patients were excluded because they were unable to maintain a Spo 2 90%. Seventyseven adults were randomly assigned to treatment: 38 patients to the 28% group and 39 patients to the 100% group. Three patients (two patients in the 28% group, and one patient in the 100% group) refused the use of the facemask. Finally, 74 patients (36 patients in the 28% group, and 38 patients in the 100% group) completed the study (mean age, years). They had severe airway obstruction (mean PEFR, % of predicted), moderate hypoxemia (mean Pao 2, mm Hg), hypocarbia (mean Paco 2, mm Hg), and normal ph ( ). Eight percent of patients (n 6) showed normoxemia and normocarbia; 76% (n 56) presented hypoxemia or normoxemia (range, 58 to 97 mm Hg) and hypocarbia (range, 28 to 39 mm Hg); and 16% of patients (n 12) presented hypoxemia (range, 63 to 90 mm Hg) and hypercarbia (range, 40 to 46 mm Hg). Table 1 shown baseline demographic data. There were no significant differences between the two groups, except for heart rate. Table 2 presents data at the end of oxygen administration (20 min). There were no differences between groups in heart and respiratory rates. Heart rate showed a trend toward a decrease, and respiratory rate was stable in both groups; however, patients treated with 100% oxygen presented a statistically significant decrease in ph (mean difference, 0.03; CHEST / 124 / 4/ OCTOBER,
3 Table 1 Demographic and Baseline Characteristics of Patients* Characteristics 28% O 2 (n 36) 100% O 2 (n 38) p Value Mean Difference (95% CI) Age, yr ( 2.5 to 6.3) Sex, male/female 24/12 (67/33) 24/14 (63/37) 0.8 Dyspnea 26 (72) 30 (79) ( 0.3 to 0.1) Wheezing 34 (94) 38 (100) ( 0.2 to 0.0) Accessory muscle use 27 (75) 30 (79) ( 0.2 to 0.1) Respiratory rate, breaths/min ( 1.7 to 2.1) Heart rate, beats/min ( 15.5 to 1.7) Predicted PEFR, L/min ( 47.6 to 18.1) PEFR, L/min (13.7 to 48.5) PEFR, % predicted ( 9.8 to 1.3) ph ( 0.0 to 0.0) Paco 2,mmHg ( 1.6 to 2.6) Pao 2,mmHg ( 2.8 to 9.1) Spo 2,% ( 0.3 to 1.8) *Data are presented as mean 1 SD or No. (%) unless otherwise indicated. 95% CI, 0.00 to 0.05) and a significant increase in Paco 2 (mean difference, 2.7 mm Hg; 95% CI, 4.7 to 0.7 mm Hg) associated with a significant decrease in PEFR (mean difference, 31.7 L/min; 95% CI, 16.7 to 46.8 L/min) compared with patients treated with 28% oxygen. As anticipated, patients who received 100% oxygen showed a substantial increase in Pao 2 compared with patients treated with 28% oxygen (mean difference, mm Hg; 95% CI, to mm Hg). Figure 1 shows the relationship between Paco 2 before and at 20 min of oxygen administration. The scatterplot revealed that this relationship is curvilinear, particularly in patients treated with 100% oxygen. We tested different curve estimation regression models, and a polynomial model was the best fit to the data. Both variables correlated significantly (r 0.53, p 0.01 in the 28% group, and r 0.88, p in the 100% group). A close examination of the relationship showed two different responses to oxygen administration. When patients received 28% oxygen, Paco 2 had a tendency to fall; on the contrary, patients who received 100% oxygen showed an increase in Paco 2, particularly in those patients with Paco 2 before oxygen treatment 40 mm Hg. Post hoc analysis of Paco 2 changes from baseline during oxygen administration are shown in Table 3. Twenty patients (55.6%) in the 28% group and 12 patients (31.6%) in the 100% group had Paco 2 decreases (p 0.05). Eight patients (22.2%) in the 28% group and eight patients (21.0%) in the 100% group (p 0.9) presented small Paco 2 increases ( 2 mm Hg) consistent with the physiologic Haldane effect. 21 Finally, only 6 patients (16.6%) in the 28% group presented a Paco 2 increase 2 mm Hg (mean increase, mm Hg; range, 2 to 5.9 mm Hg), compared with 16 patients (42.1%) [mean increase, mm Hg; range, 2.4 to 14.3 mm Hg] in the 100% group (p 0.02). At the end of the protocol, this subgroup of patients showed a significant differ- Table 2 Heart and Respiratory Rates, Pulmonary Function, and Arterial Blood Gas Levels at 20 min of Oxygen Administration* Variables 28% O 2 (n 36) 100% O 2 (n 38) p Value Mean Difference (95% CI) Respiratory rate, breaths/min ( 2.1 to 1.2) Respiratory rate variation, breaths/min ( 0.9 to 1.5) Heart rate, beats/min (11.8 to 2.5) Heart rate variation, beats/min ( 0.6 to 6.3) PEFR, L/min ( 30.2 to 35.5) PEFR, variation, L/min (16.7 to 46.8) ph (0.00 to 0.05) ph variation (0.00 to 0.04) Paco 2,mmHg ( 4.7 to 0.7) Paco 2 variation, mm Hg ( 4.9 to 1.3) Pao 2,mmHg ( to 131.8) *Data are presented as mean 1 SD unless otherwise indicated Clinical Investigations
4 Figure 1. Paco 2 during oxygen administration as a function of Paco 2 before oxygen treatment. The variables correlated significantly in both groups (p 0.01). Patients breathing 28% oxygen had a Paco 2 fall (left panel); on the contrary, patients who received 100% oxygen showed an increase in Paco 2, particularly those with Paco 2 before oxygen treatment 40 mm Hg (right panel). ence in PEFR (PEFR deterioration of L/min in the 100% group, compared with an increase of L/min in the 28% group, p 0.03). Whereas Paco 2 did not correlate with PEFR in the 28% group (r 0.21, p 0.6), the 100% group showed an inverse curvilinear correlation between PEFR before oxygen administration and Paco 2 during oxygen treatment (Fig 2). Low values of PEFR were associated with high levels of Paco 2 (r 0.53, p 0.01, polynomial model). Discussion To our knowledge, this is the first randomized controlled trial that provided data on the effect of two oxygen concentrations on Paco 2 and PEFR in adult patients with acute severe asthma. The results showed that 100% of inspired oxygen resulted in a significant increase in Paco 2. Forty-two percent of the 100% oxygen group patients had increases in Paco 2 averaging 5.0 mm Hg (range, 2.4 to 14.3 mm Hg). As shown in Figures 1 and 2, Paco 2 during oxygen administration highly correlated with the Paco 2 level before oxygen treatment and moderately with the baseline airway obstruction (PEFR). Thus, baseline Paco 2 and PEFR 40 mm Hg and 35% of predicted respectively appears to be significant factors in the development of hyperoxic-induced hypercapnia. Additionally, the gas exchange deterioration was associated with a significant decrease in pulmonary function. On the contrary, the administration of 28% oxygen overall improved the patient condition. Thus, low oxygen concentration rectified hypoxemia (mean Pao 2 at the end of protocol, mm Hg), produced a small mean Paco 2 decrease ( mm Hg), and improved pulmonary function ( L/min). In spite of this, 16.6% of patients experienced an increase in Paco 2 (range, 2.0 to 5.9 mm Hg). These findings are in accordance with previous studies. More than 10 years ago, two noncontrolled trials 22,23 found that acute asthma patients treated with high inspired oxygen concentration presented a significant increase in Paco 2 (of the order of 3 to 5 mm Hg). More recently, Chien et al 12 demonstrated that the administration of 100% oxygen to acute asthma patients with moderate-to-severe airway obstruction (FEV 1 of 49.1% of predicted) may adversely influence carbon dioxide elimination. With 100% oxygen administration, FEV 1 fell by 4.3%, ph Table 3 Distribution of PaCO 2 Changes From Baseline During Oxygen Administration* Paco 2 Change 28% O 2 (n 36) 100% O 2 (n 38) p Value Mean Difference (95% CI) No change 2 (5.6) 2 (5.3) ( 0.12 to 0.13) Fall 1 mm Hg 20 (55.6) 12 (31.6) (0.02 to 0.43) Rise 2 mm Hg (Haldane effect) 8 (22.2) 8 (21.0) ( 0.17 to 0.19) Rise 2 mm Hg 6 (16.6) 16 (42.1) ( 0.43 to 0.05) *Data are presented as No. (%) unless otherwise indicated. CHEST / 124 / 4/ OCTOBER,
5 Figure 2. Relationship between airway obstruction before oxygen administration as measured by PEFR (as percentage of predicted) and Paco 2 during the administration of 100% oxygen. Low values of PEFR were associated with high levels of Paco 2 (r 0.54, p 0.01). decreased by 0.02, and Paco 2 rose by 2.3 mm Hg). Almost 41% of patients had elevations in Paco 2 2 mm Hg, averaging 5.9 mm Hg. In general, the tendency toward hypercarbia was the greatest in the patients with the most abnormal baseline condition (FEV 1 and Paco 2 ). Although our study did not look closely at any changes in minute ventilation, there seemed to be no significant modifications before and during oxygen administration in respiratory rate. Hyperoxia associated with hypercarbia occurring in asthma exacerbations, and especially without any evidence of respiratory suppression, would be more easily explained by the regional release of hypoxic pulmonary vasoconstriction. This factor had a major role in determining V /Q matching, as V /Q inequality worsened considerably after administration of 100% oxygen. This has been shown in patients with acute asthma receiving ventilation and not receiving ventilation 22,23 ; therefore, patients with most severe baseline condition probably have more hypoxic vasoconstriction, and they had the greatest increase in Paco 2 while breathing 100% oxygen. Our trial sample presented the typical features of severe adult asthmatic patients when they presented for care to an emergency department on average: a mean level of PEFR of 41% of predicted, a mean age of 38 years, and a female/male ratio of 2:1. Finally, 76% of our patients presented the most characteristic arterial blood gas pattern: mild-to-moderate hypoxemia (range, 58 to 97 mm Hg) along with hypocapnia (range, 28 to 39 mm Hg). 24,25 In summary in this randomized, controlled trial, we have confirmed previous observations that administration of 100% oxygen for 20 min significantly increases Paco 2 and decreases PEFR as compared with administration of 28% oxygen. These observations strongly support Global Strategy for Asthma Management and Prevention recommendations 15 that oxygen dose in severe acute asthma should be variable and should be based on achieving and maintaining target Spo 2 values with a pulse oximeter 92% for adults 26 and 95% for children. Because severe asthma may give rise to hypoxemia and -agonist therapy may worsen hypoxemia, monitoring therapy of acute asthma with pulse oximetry is ideal. 27 The results should be used to control the administration and dose of oxygen therapy. In circumstances where acute asthma must be treated without pulse oximetry, a clinical judgment must be made as to whether oxygen therapy (if is available) is warranted to prevent life-threatening hypoxemia, despite its potential adverse effects. However, uncontrolled high-flow oxygen should be avoided. References 1 Molfino NA, Nannini LJ, Martelli AN, et al. Respiratory arrest in near-fatal asthma. N Engl J Med 1991; 324: Molfino NA. Near-fatal asthma. In: Hall JB, Corbridge T, Rodrigo C, et al, eds. Acute asthma: assessment and management. New York, NY: McGraw-Hill, 2000; National Asthma Education and Prevention Program. Expert panel report 2: Guidelines for the diagnosis and management of asthma. Bethesda, MD. National Institutes of Health, 1997; publication No British guidelines on asthma management 1995: review and position statement. Thorax 1997; 53(Suppl):S1 S24 5 Canadian asthma consensus report. Management of patients with asthma in the emergency department and in hospital. Can Med Assoc J 1999; 161(Suppl):S53 S59 6 Rodriguez-Roisin R. Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. Eur Respir J 1997; 10: Rodriguez-Roisin R. Gas exchange in acute asthma. In: Hall JB, Corbridge T, Rodrigo C, et al, eds. Acute asthma: assessment and management. New York, NY: McGraw-Hill, 2000; British Thoracic Society and others. Guidelines for the management of asthma: management of acute asthma. Thorax 2003; 58:i32 i50 9 Scottish Intercollegiate Guidelines Network. Emergency management of acute asthma: a national clinical guideline. Edinburgh, Scotland: Scottish Intercollegiate Guidelines Network, 1999; Sign Publication No Inwald D, Roland M, Kuitert S, et al. Oxygen treatment for acute severe asthma. BMJ 2001; 323: Werner HA. Status asthmaticus in children: a review. Chest 2001; 119: Chien JW, Ciufo R, Novak R, et al. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000; 117: Clinical Investigations
6 13 FitzGerald M. Extracts from clinical evidence : acute asthma. BMJ 2001; 323: Thomson AJ, Webb DJ, Maxwell SR. Oxygen therapy in acute medical care: the potential dangers of hyperoxia need to be recognised. BMJ 2002; 321: NHLBI/WHO workshop report. Global strategy for asthma management and prevention. Bethesda, MD: National Institutes of Health, 2002; Publication No American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: Rodrigo C, Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest 1998; 113: Rodrigo GJ, Rodrigo C. The role of anticholinergics in acute asthma treatment: an evidence-based evaluation. Chest 2002; 121: McFadden ER, Kiser R, degroot WJ. Acute bronchial asthma: relations between clinical and physiologic manifestations. N Engl J Med 1973; 288: Altman DG, Machin D, Bryant TN, et al. Statistics with confidence. Bristol, UK: BMJ Books, Lenfant C. Arterial-alveolar difference in Pco 2 during air and oxygen breathing. J Appl Physiol 1966; 21: Rodriguez-Roisin R, Ballester E, Torres A, et al. Mechanisms of abnormal gas exchange in patients with status asthmaticus needing mechanical ventilation. Am Rev Respir Dis 1989; 139: Ballester E, Reyes R, Roca J, et al. Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax 1989; 44: Tai E, Read J. Arterial-blood gas tension in asthma. Lancet 1967; 1: McFadden ER, Lyons H. Arterial blood gas tension in asthma. N Engl J Med 1968; 278: Carruthers DM, Harrison BDW. Arterial blood gas analysis or oxygen saturation in the assessment of acute asthma? Thorax 1995; 50: Rodrigo GJ. Oxygen treatment for acute severe asthma: oxygen saturation may help identify patients in need of intensive management [letter]. BMJ 2001; 323: CHEST / 124 / 4/ OCTOBER,
Asthma is global health problem in children,
Paediatrica Indonesiana VOLUME 52 July NUMBER 4 Original Article Efficacy of salbutamol-ipratropium bromide nebulization compared to salbutamol alone in children with mild to moderate asthma attacks Matahari
More informationLecture Notes. Chapter 3: Asthma
Lecture Notes Chapter 3: Asthma Objectives Define asthma and status asthmaticus List the potential causes of asthma attacks Describe the effect of asthma attacks on lung function List the clinical features
More informationCOPD Challenge CASE PRESENTATION
Chronic obstructive pulmonary disease (COPD) exacerbations may make up more than 10% of acute medical admissions [1], and they are increasingly recognised as a cause of significant morbidity and mortality
More informationRandomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma
See Editorial, p 931 < Additional tables are published online only. To view these files please visit the journal online (http://thorax.bmj. com). 1 Medical Research Institute of New Zealand, Wellington,
More informationEfficacy of Nebulised Ipratropium in Acute Bronchial Asthma
ORIGINAL ARTICLE JIACM 2002; 3(4): 353-59 Efficacy of Nebulised Ipratropium in Acute Bronchial Asthma Praveen Aggarwal*, Onkar Singh**, Jyoti P Wali***, Rohini Handa*, Sada N Dwivedi****, Ashutosh Biswas*****,
More informationGustavo J. Rodrigo, MD; Carlos Rodrigo, MD; Charles V. Pollack, MD; and Brian Rowe, MD, MSc, CCFP (EM)
Use of Helium-Oxygen Mixtures in the Treatment of Acute Asthma* A Systematic Review Gustavo J. Rodrigo, MD; Carlos Rodrigo, MD; Charles V. Pollack, MD; and Brian Rowe, MD, MSc, CCFP (EM) Study objective:
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationCorrelations between pulse oximetry and peak expiratory flow in acute asthma
Brazilian Journal of Medical and Biological Research (2007) 40: 485-490 Pulse oximetry and peak expiratory flow in acute asthma ISSN 0100-879X 485 Correlations between pulse oximetry and peak expiratory
More informationKey words: acute asthma treatment; albuterol; -agonists; intermittent or continuous nebulization
Continuous vs Intermittent -Agonists in the Treatment of Acute Adult Asthma* A Systematic Review With Meta-analysis Gustavo J. Rodrigo, MD; and Carlos Rodrigo, MD Background: Since the late 1980s, there
More informationManagement of acute asthma in children in emergency department. Moderate asthma
152 Moderate asthma SpO2 92% No clinical features of severe asthma NB: If a patient has signs and symptoms across categories, always treat according to their most severe features agonist 2-10 puffs via
More informationSupplementary Medications during asthma attack. Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus
Supplementary Medications during asthma attack Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus Conflicts of Interest None Definition of Asthma Airway narrowing that is
More informationOver the last several years various national and
Recommendations for the Management of COPD* Gary T. Ferguson, MD, FCCP Three sets of guidelines for the management of COPD that are widely recognized (from the European Respiratory Society [ERS], American
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. The synopsis
More informationBasic mechanisms disturbing lung function and gas exchange
Basic mechanisms disturbing lung function and gas exchange Blagoi Marinov, MD, PhD Pathophysiology Department, Medical University of Plovdiv Respiratory system 1 Control of breathing Structure of the lungs
More informationBi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients
Bi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients Objectives Describe nocturnal ventilation characteristics that may indicate underlying conditions and benefits of bilevel therapy for specific
More information1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation.
Chapter 1: Principles of Mechanical Ventilation TRUE/FALSE 1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation. F
More informationASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides
BRONCHIAL ASTHMA ASTHMA Epidemiology Pathophysiology Diagnosis 2 CHILDHOOD ASTHMA Childhood bronchial asthma is characterized by Airway obstruction which is reversible Airway inflammation Airway hyper
More informationAppendix E Choose the sign or symptom that best indicates severe respiratory distress.
Appendix E-2 1. In Kansas EMT-B may monitor pulse oximetry: a. after they complete the EMT-B course b. when the service purchases the state approved pulse oximeters c. when the service director receives
More informationSignificance. Asthma Definition. Focus on Asthma
Focus on Asthma (Relates to Chapter 29, Nursing Management: Obstructive Pulmonary Diseases, in the textbook) Asthma Definition Chronic inflammatory disorder of airways Causes airway hyperresponsiveness
More informationNoninvasive positive pressure ventilation improves
A Pilot Prospective, Randomized, Placebo-Controlled Trial of Bilevel Positive Airway Pressure in Acute Asthmatic Attack* Arie Soroksky, MD; David Stav, MD; and Isaac Shpirer, MD Study objective: Noninvasive
More informationManagement of acute severe asthma in adults in general practice. Moderate asthma Acute severe asthma Life-threatening asthma INITIAL ASSESSMENT
British guideline on the management of asthma Annex 2 Management of acute severe asthma in adults in general practice Many deaths from asthma are preventable. Delay can be fatal. Factors leading to poor
More informationManagement of Acute Asthma Exacerbations in Children 2012 Update. Sharon Kling Dept Paediatrics & Child Health University of Stellenbosch
Management of Acute Asthma Exacerbations in Children 2012 Update Sharon Kling Dept Paediatrics & Child Health University of Stellenbosch Acknowledgements BTS/SIGN guidelines GINA guidelines NAEPP guidelines
More informationEffects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease
et al. DOI:10.1111/j.1365-2125.2006.02604.x British Journal of Clinical Pharmacology Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease
More informationPulmonary Pathophysiology
Pulmonary Pathophysiology 1 Reduction of Pulmonary Function 1. Inadequate blood flow to the lungs hypoperfusion 2. Inadequate air flow to the alveoli - hypoventilation 2 Signs and Symptoms of Pulmonary
More informationGINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017
GINA At-A-Glance Asthma Management Reference for adults, adolescents and children 6 11 years Updated 2017 This resource should be used in conjunction with the Global Strategy for Asthma Management and
More informationRespiratory Pathophysiology Cases Linda Costanzo Ph.D.
Respiratory Pathophysiology Cases Linda Costanzo Ph.D. I. Case of Pulmonary Fibrosis Susan was diagnosed 3 years ago with diffuse interstitial pulmonary fibrosis. She tries to continue normal activities,
More informationARTERIAL BLOOD GAS ANALYSIS IN ACUTE AND CHRONIC BRONCHIAL ASTHMA
Research Article E-ISSN 2341-4103 ARTERIAL BLOOD GAS ANALYSIS IN ACUTE AND CHRONIC BRONCHIAL PADMAVATHI. K, SUMANGALI.P, SUBASH.Y.E @ Assistant professor, Department of Physiology, Siddhartha Medical College,
More informationOxygenation. Chapter 45. Re'eda Almashagba 1
Oxygenation Chapter 45 Re'eda Almashagba 1 Respiratory Physiology Structure and function Breathing: inspiration, expiration Lung volumes and capacities Pulmonary circulation Respiratory gas exchange: oxygen,
More informationExacerbations. Ronald Dahl, Aarhus University Hospital, Denmark
1st WAO Allied Health Session - Asthma: Diagnosi Exacerbations Ronald Dahl, Aarhus University Hospital, Denmark The health professional that care for patients with asthma exacerbation must be able to Identificafy
More informationRon Hosp, MS-HSA, RRT Regional Respiratory Specialist. This program has been approved for 1 hour of continuing education credit.
Ron Hosp, MS-HSA, RRT Regional Respiratory Specialist This program has been approved for 1 hour of continuing education credit. Course Objectives Identify at least four goals of home NIV Identify candidates
More informationCOPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis.
1 Definition of COPD: COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis. Airflow obstruction may be accompanied by airway hyper-responsiveness
More informationLecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD)
Lecture Notes Chapter 4: Chronic Obstructive Pulmonary Disease (COPD) Objectives Define COPD Estimate incidence of COPD in the US Define factors associated with onset of COPD Describe the clinical features
More informationI. Subject: Continuous Aerosolization of Bronchodilators
I. Subject: Continuous Aerosolization of Bronchodilators II. Indications: A. Acute airflow obstruction in which treatment with an aerosolized bronchodilator is desired for an extended period of time, i.e.
More informationRespiratory Medicine. Some pet peeves and other random topics. Kyle Perrin
Respiratory Medicine Some pet peeves and other random topics Kyle Perrin Overview 1. Acute asthma Severity assessment and management 2. Acute COPD NIV and other management 3. Respiratory problems in the
More informationOn completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationNguyen Tien Dung A/Prof. PhD. MD Head of Pediatric Department - Bach Mai Hospital
Nguyen Tien Dung A/Prof. PhD. MD Head of Pediatric Department - Bach Mai Hospital A girl patient 11 years old admitted to Bach mai Hospital at 4h15, 12nd November because of difficult breathing She has
More informationBronchospasm & SOB. Kim Kilmurray Senior Clinical Teaching Fellow
Bronchospasm & SOB Kim Kilmurray Senior Clinical Teaching Fellow LEARNING OBJECTIVES Perform a comprehensive respiratory examination & link clinical signs to underlying pathology Identify the spectrum
More information10/6/2014. Tommy s Story: An Overview of Asthma Mangement. Disclosure. Objectives for this talk.
Tommy s Story: An Overview of Asthma Mangement Clifton C. Lee, MD, FAAP, FHM Associate Professor of Pediatrics Chief, Pediatric Hospital Medicine Children s Hospital of Richmond at VCU Disclosure Obviously,
More informationRespiratory Emergencies. Chapter 11
Respiratory Emergencies Chapter 11 Respiratory System Anatomy and Function of the Lung Characteristics of Adequate Breathing Normal rate and depth Regular breathing pattern Good breath sounds on both sides
More informationTreatment of Acute Asthma*
Treatment of Acute Asthma* Lack of Therapeutic Benefit and Increase of the Toxicity From Aminophylline Given in Addition to High Doses of Salbutamol Delivered by Metered-Dose Inhaler With a Spacer Carlos
More informationChronic Obstructive Pulmonary Disease
136 PHYSIOLOGY CASES AND PROBLEMS Case 24 Chronic Obstructive Pulmonary Disease Bernice Betweiler is a 73-year-old retired seamstress who has never been married. She worked in the alterations department
More informationMedical Emergencies at Moderate and High Altitude
Medical Emergencies at Moderate and High Altitude Annalisa Cogo Clinica Pneumologica e Centro Studi Biomedici Applicati allo Sport Università di Ferrara Payer Hutte, Ortler Mountain Environment Barometric
More informationCourse Handouts & Disclosure
COPD: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Hospice Education Network Course Handouts & Disclosure To download presentation
More informationORIGINAL RESEARCH ARTICLE. A. Mirici, M. Meral and M. Akgun. Abstract
ORIGINAL RESEARCH ARTICLE Clin Drug Invest 2003; 23 (1): 55-62 1173-2563/03/0001-0055/$230.00/0 Adis International Limited. All rights reserved. Comparison of the Efficacy of Nebulised Budesonide with
More informationCompetency Title: Continuous Positive Airway Pressure
Competency Title: Continuous Positive Airway Pressure Trainee Name: ------------------------------------------------------------- Title: ---------------------------------------------------------------
More informationEmergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE
Emergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE Indications for Vapotherm High Velocity Nasal Insufflation (Hi-VNI ) administration, the patient should be: Spontaneously
More informationa. Will not suppress respiratory drive in acute asthma
Status Asthmaticus & COPD with Respiratory Failure - Key Points M.J. Betzner MD FRCPc - NYEMU Toronto 2018 Overview This talk is about the sickest of the sick patients presenting with severe or near death
More informationNEBULIZED SALBUTAMOL WITH & WITHOUT IPRATROPIUM BROMIDE IN THE TREATMENT OF ACUTE SEVERE ASTHMA
NEBULIZED SALBUTAMOL WITH & WITHOUT IPRATROPIUM BROMIDE IN THE TREATMENT OF ACUTE SEVERE ASTHMA Naveed Inayat*, Riaz Hussain Shah**, Qurban Ali Rahu***, Rubina Sahito* ORIGINAL ARTICLE *Department of Pulmonology,
More informationParamedic Rounds. Pre-Hospital Continuous Positive Airway Pressure (CPAP)
Paramedic Rounds Pre-Hospital Continuous Positive Airway Pressure (CPAP) Morgan Hillier MD Class of 2011 Dr. Mike Peddle Assistant Medical Director SWORBHP Objectives Outline evidence for pre-hospital
More informationO ver the last two decades, British guidelines
447 REVIEW SERIES Asthma exacerbations? 5: Assessment and management of severe asthma in adults in hospital Sarah Aldington, Richard Beasley... It is difficult to understand why there is such a huge discrepancy
More informationIt is recommended that a mask and protective eyewear be worn when providing care to a patient with a cough
UNIVERSITY HEALTH NETWORK POLICY #: PAGE 1 OF 7 POLICY AND PROCEDURE MANUAL: RESPIRATORY THERAPY DEPT PATIENT CARE SECTION ORIGINAL DATE: 04/03 ISSUED BY: SITE LEADER APPROVED BY: Infection Prevention
More informationNorthwest Community EMS System Continuing Education Class Credit Questions Respiratory Assessment January 2012
Name (PRINT): Date submitted: Affiliation: Rating: [ ] Complete [ ] Incomplete Reminder: You must schedule to take the class post-test with your assigned hospital EMS Coordinator/educator or their designee
More informationThis is a cross-sectional analysis of the National Health and Nutrition Examination
SUPPLEMENTAL METHODS Study Design and Setting This is a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010, and 2011-2012. The NHANES is
More informationPost Arrest Ventilation/Oxygenation Management
Post Arrest Ventilation/Oxygenation Management Richard Branson MSc RRT Professor of Surgery University of Cincinnati Editor-In-Chief Respiratory Care 0 Presenter Disclosure Information Richard Branson
More informationPATHOPHYSIOLOGICAL PROCESS TEMPLATE
1 PATHOPHYSIOLOGICAL PROCESS TEMPLATE DISEASE: Chronic obstructive pulmonary disease (COPD) DEFINITION: COPD can be defined as a disease in which there is a significant damage to the lungs thus reducing
More informationOxygen therapy increases the arterial partial pressure of
High flow or titrated oxygen for obese medical inpatients: a randomised crossover trial Janine Pilcher 1, Michael Richards 1, Leonie Eastlake 1, Steven J McKinstry 1, George Bardsley 1, Sarah Jefferies
More informationRespiratory Anesthetic Emergencies in Oral and Maxillofacial Surgery. By: Lillian Han
Respiratory Anesthetic Emergencies in Oral and Maxillofacial Surgery By: Lillian Han Background: Respiratory anesthetic emergencies are the most common complications during the administration of anesthesia
More informationOxygen prescription and administration at the Emergency Department and medical wards in Mater Dei Hospital
Original Article Oxygen prescription and administration at the Emergency Department and medical wards in Mater Dei Hospital Rachelle Asciak, Valerie Anne Fenech, Jurgen Gatt, Stephen Montefort Abstract
More informationNBRC Exam RPFT Registry Examination for Advanced Pulmonary Function Technologists Version: 6.0 [ Total Questions: 111 ]
s@lm@n NBRC Exam RPFT Registry Examination for Advanced Pulmonary Function Technologists Version: 6.0 [ Total Questions: 111 ] https://certkill.com NBRC RPFT : Practice Test Question No : 1 Using a peak
More informationEmergency Asthma Care
Emergency Asthma Care Contents Introduction 3 Why good emergency asthma care is important 4 Access to emergency asthma care 5 How to improve emergency asthma care 6 Developing emergency asthma treatment
More informationJournal of Emergency Primary Health Care (JEPHC), Vol. 6, Issue 1, 2008 CLINICAL PRACTICE. Article
ISSN 1447-4999 CLINICAL PRACTICE Article 990280 The quandary of prehospital oxygen administration in chronic obstructive pulmonary disease - a review of the literature Elizabeth Perry, BPhysio, BEmergHealth(Paramedic)
More informationNIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP)
Introduction NIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP) Noninvasive ventilation (NIV) is a method of delivering oxygen by positive pressure mask that allows for the prevention or postponement of invasive
More informationبسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Yesterday we spoke of the increased airway resistance and its two examples: 1) emphysema, where we have destruction of the alveolar wall and thus reducing the area available for
More informationAppendix D An unresponsive patient with shallow, gasping breaths at a rate of six per minute requires:
Answer Key Appendix D-2 1. An unresponsive patient with shallow, gasping breaths at a rate of six per minute requires: a. oxygen given via nasal cannula b. immediate transport to a medical facility c.
More informationCOPD. Breathing Made Easier
COPD Breathing Made Easier Catherine E. Cooke, PharmD, BCPS, PAHM Independent Consultant, PosiHleath Clinical Associate Professor, University of Maryland School of Pharmacy This program has been brought
More informationRelevant Papers: eight relevant articles were found, but four were reviewed because they were most directly related to the topic
Topic: Prehospital use of bromide paired with salbutamol as treatment for shortness of breath. Author: Lisa Henderson Clinical Scenario: Two primary care paramedics respond code 4 for a 55 year old male
More informationOXYGEN USE IN PHYSICAL THERAPY PRACTICE. Rebecca H. Crouch, PT,DPT,MS,CCS,FAACVPR
OXYGEN USE IN PHYSICAL THERAPY PRACTICE Rebecca H. Crouch, PT,DPT,MS,CCS,FAACVPR Supplemental Oxygen Advantages British Medical Research Council Clinical Trial Improved survival using oxygen 15 hrs/day
More informationDATE: 09 December 2009 CONTEXT AND POLICY ISSUES:
TITLE: Tiotropium Compared with Ipratropium for Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease: A Review of the Clinical Effectiveness DATE: 09 December 2009 CONTEXT AND POLICY
More informationAsthma/wheeze management plan
Asthma/wheeze management plan Name of Patient Date of Birth NHS Number GP surgery Telephone Next appointment Children s Assessment unit/ward telephone Out of hours call 111 Open access Y/N Until date Some
More informationCapnography 101. James A Temple BA, NRP, CCP
Capnography 101 James A Temple BA, NRP, CCP Expected Outcomes 1. Gain a working knowledge of the physiology and science behind End-Tidal CO2. 2.Relate End-Tidal CO2 to ventilation, perfusion, and metabolism.
More informationAnatomy and Physiology
Anatomy and Physiology Respiratory Diagnostic Procedures 2004 Delmar Learning, a Division of Thomson Learning, Inc. Bell Work Complete cost of smoking exercise. We will go over this together! (Don t worry)!
More informationDirect and indirect CV effects of current drugs and those in development
Direct and indirect CV effects of current drugs and those in development Heribert Staudinger CSRC MARCH 201 Cardiac Manifestations of COPD Cardiovascular Disease is probably the most frequent and most
More informationArterial Blood Gas Analysis
Arterial Blood Gas Analysis L Lester www.3bv.org Bones, Brains & Blood Vessels Drawn from radial or femoral arteries. Invasive procedure Caution must be taken with patient on anticoagulants ph: 7.35-7.45
More informationOxygen: Is there a problem? Tom Heaps Acute Physician
Oxygen: Is there a problem? Tom Heaps Acute Physician Case 1 79-year-old female, diabetic, morbidly obese Admitted with LVF Overnight Reduced GCS?cause 15l NRB in situ ABG showed ph 6.9, pco 2 15.9kPa
More informationPEDIATRIC ACUTE ASTHMA SCORE (P.A.A.S.) GUIDELINES. >97% 94% to 96% 91%-93% <90% Moderate to severe expiratory wheeze
Inclusion: Children experiencing acute asthma exacerbation 24 months to 18 years of age with a diagnosis of asthma Patients with a previous history of asthma (Consider differential diagnosis for infants
More informationTitle Protocol for the Management of Asthma
Document Control Title Protocol for the Management of Asthma Author Author s job title Professional Lead, Minor Injuries Unit Directorate Emergency Services, Logistics and Resilience Department Version
More informationOverview. The Respiratory System. Chapter 18. Respiratory Emergencies 9/11/2012
Chapter 18 Respiratory Emergencies Slide 1 Overview Respiratory System Review Anatomy Physiology Breathing Assessment Adequate Breathing Breathing Difficulty Focused History and Physical Examination Emergency
More informationGas exchange, expiratory flow obstruction and the clinical spectrum of asthma
ur Respir J, 1996, 9, 1278 1282 OI: 1.1183/931936.96.961278 Printed in UK - all rights reserved opyright RS Journals Ltd 1996 uropean Respiratory Journal ISSN 93-1936 POINT OF VIW Gas exchange, expiratory
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Vol 120 No 1267 ISSN 1175 8716 Is Salamol less effective than Ventolin? A randomised, blinded, crossover study in New Zealand Catherina L Chang, Manisha Cooray, Graham Mills,
More informationAsthma. chapter 7. Overview
chapter 7 Asthma Sinus Sinus Sinus Right lung Adenoids Tonsils Pharynx Epiglottis Oesophagus Right bronchus Nasal cavity Oral cavity Tongue Larynx Trachea Ribs Left bronchus Diaphragm Bronchiole Pleura
More informationChapter 11: Respiratory Emergencies
29698_CH11_ANS_p001_005 4/12/05 2:02 PM Page 1 Answer Key Chapter 11 1 Chapter 11: Respiratory Emergencies Matching 1. B (page 373) 8. E (page 370) 2. D (page 369) 9. M(page 389) 3. H (page 370) 10. A
More informationMedicine Dr. Kawa Lecture 4 - Treatment of asthma :
Medicine Dr. Kawa Lecture 4 - Treatment of asthma : Avoiding allergens. Hyposensitization :Subcutaneous injections of inially very small, but gradually increasing doses of allergens (desensitization or
More informationAECOPD: Management and Prevention
Neil MacIntyre MD Duke University Medical Center Durham NC Professor P.J. Barnes, MD, National Heart and Lung Institute, London UK Professor Peter J. Barnes, MD National Heart and Lung Institute, London
More informationFunction of the Respiratory System. Exchange CO2 (on expiration) for O2 (on inspiration)
Function of the Respiratory System Exchange CO2 (on expiration) for O2 (on inspiration) Upper Respiratory Tract Includes: Nose Mouth Pharynx Larynx Function: Warms and humidifies the inspired air Filters
More informationDisclosure and Conflict of Interest 8/15/2017. Pharmacist Objectives. At the conclusion of this program, the pharmacist will be able to:
Digging for GOLD Rebecca Young, PharmD, BCACP, Roosevelt University College of Pharmacy Assistant Professor of Clinical Sciences Practice Site Advocate Medical Group-Nesset Pavilion Disclosure and Conflict
More informationCOPD/ Asthma. Dr Heather Lewis Honorary Clinical Lecturer
COPD/ Asthma Dr Heather Lewis Honorary Clinical Lecturer Objectives To understand the pathogenesis of asthma/ COPD To recognise the clinical features of asthma/ COPD To know how to diagnose asthma/ COPD
More informationAsthma Care in the Emergency Department Clinical Practice Guideline
Asthma Care in the Emergency Department Clinical Practice Guideline Inclusion: 1) Children 2 years of age or older with a prior history of wheezing, and 2) Children less than 2 years of age with likely
More informationRespiratory Failure. Causes of Acute Respiratory Failure (ARF): a- Intrapulmonary:
Respiratory failure exists whenever the exchange of O 2 for CO 2 in the lungs cannot keep up with the rate of O 2 consumption & CO 2 production in the cells of the body. This results in a fall in arterial
More informationTORCH: Salmeterol and Fluticasone Propionate and Survival in COPD
TORCH: and Propionate and Survival in COPD April 19, 2007 Justin Lee Pharmacy Resident University Health Network Outline Overview of COPD Pathophysiology Pharmacological Treatment Overview of the TORCH
More informationEffect of nifedipine on arterial hypoxaemia occurring
Thorax 1986;41:468-472 Effect of nifedipine on arterial hypoxaemia occurring after methacholine challenge in asthma E BALLESTER, J ROCA, R RODRIGUEZ-ROISIN, A AGUSTI-VIDAL From the Servei de Pneumologia,
More informationRelationship Between FEV1& PEF in Patients with Obstructive Airway Diseases
OBSTRUCTIVE THE IRAQI POSTGRADUATE AIRWAY MEDICAL DISEASES JOURNAL Relationship Between FEV1& PEF in Patients with Obstructive Airway Diseases Muhammed.W.AL.Obaidy *, Kassim Mhamed Sultan*,Basil Fawzi
More information2/12/2015. ASTHMA & COPD The Yin &Yang. Asthma General Information. Asthma General Information
ASTHMA & COPD The Yin &Yang Arizona State Association of Physician Assistants March 6, 2015 Sedona, Arizona Randy D. Danielsen, PhD, PA-C, DFAAPA Dean & Professor A.T. Still University Asthma General Information
More informationPrinted copies of this document may not be up to date, obtain the most recent version from
Children s Acute Transport Service Clinical Guidelines Acute Severe Asthma Document Control Information Author E Randle Author Position CATS Consultant Document Owner E Polke Document Owner Position Co-ordinator
More informationβ 2004 2004 o β β β β 2004 β β β β β β β β β 2004 2004 2004 2004 2004 β 2004 2004 2004 2004 β β 2004 β β β β β β β 2004 β β β β β β 2004 β β β β STEP 5: CONTINUOUS OR FREQUENT USE OF ORAL
More informationEffect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD
Respiratory Medicine (2006) 100, 212 217 Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD M. Cazzola a,, P. Noschese a, F. De Michele b, G.
More informationAsthma Management for the Athlete
Asthma Management for the Athlete Khanh Lai, MD Assistant Professor Division of Pediatric Pulmonary and Sleep Medicine University of Utah School of Medicine 2 nd Annual Sports Medicine Symposium: The Pediatric
More informationLab 4: Respiratory Physiology and Pathophysiology
Lab 4: Respiratory Physiology and Pathophysiology This exercise is completed as an in class activity and including the time for the PhysioEx 9.0 demonstration this activity requires ~ 1 hour to complete
More informationUpdate on heterogeneity of COPD, evaluation of COPD severity and exacerbation
Update on heterogeneity of COPD, evaluation of COPD severity and exacerbation Yung-Yang Liu, MD Taipei Veterans General Hospital Aug 29, 2015 G O lobal Initiative for Chronic bstructive L D ung isease
More informationACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv.8.18.18 ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) SUDDEN PROGRESSIVE FORM OF ACUTE RESPIRATORY FAILURE ALVEOLAR CAPILLARY MEMBRANE BECOMES DAMAGED AND MORE
More information